|
1
|
PDQ Screening Prevention Editorial Board:
Stomach (Gastric) Cancer Prevention (PDQ): Health Professional
Version. http://www.cancer.gov/types/stomach/hp/stomach-prevention-pdqAccessed.
February 05–2016
|
|
2
|
Guo HQ, Guan P, Shi HL, Zhang X, Zhou BS
and Yuan Y: Prospective cohort study of comprehensive prevention to
gastric cancer. World J Gastroenterol. 9:432–436. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guo X and Zhao B: Integration of
mechanical and chemical signals by YAP and TAZ transcription
coactivators. Cell Biosci. 3:332013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hong W: Angiomotin'g YAP into the nucleus
for cell proliferation and cancer development. Sci Signal.
6:pe272013.PubMed/NCBI
|
|
5
|
Overholtzer M, Zhang J, Smolen GA, Muir B,
Li W, Sgroi DC, Deng CX, Brugge JS and Haber DA: Transforming
properties of YAP, a candidate oncogene on the chromosome 11q22
amplicon. Proc Natl Acad Sci USA. 103:12405–12410. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xiao W, Wang J, Ou C, Zhang Y, Ma L, Weng
W, Pan Q and Sun F: Mutual interaction between YAP and c-Myc is
critical for carcinogenesis in liver cancer. Biochem Biophys Res
Commun. 439:167–172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu-Chittenden Y, Huang B, Shim JS, Chen
Q, Lee SJ, Anders RA, Liu JO and Pan D: Genetic and pharmacological
disruption of the TEAD-YAP complex suppresses the oncogenic
activity of YAP. Genes Dev. 26:1300–1305. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Felley-Bosco E and Stahel R: Hippo/YAP
pathway for targeted therapy. Transl Lung Cancer Res. 3:75–83.
2014.PubMed/NCBI
|
|
9
|
Okamoto K and Murawaki Y: The therapeutic
potential of RNA interference: Novel approaches for cancer
treatment. Curr Pharm Biotechnol. 13:2235–2247. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou Z, Zhu JS and Xu ZP: RNA interference
mediated YAP gene silencing inhibits invasion and metastasis of
human gastric cancer cell line SGC-7901. Hepatogastroenterology.
58:2156–2161. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou Z, Zhu JS, Xu ZP and Zhang Q:
Lentiviral vector-mediated siRNA knockdown of the YAP gene inhibits
growth and induces apoptosis in the SGC7901 gastric cancer cell
line. Mol Med Rep. 4:1075–1082. 2011.PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li LT, Jiang G, Chen Q and Zheng JN: Ki67
is a promising molecular target in the diagnosis of cancer
(review). Mol Med Rep. 11:1566–1572. 2015.PubMed/NCBI
|
|
14
|
Pestell RG: New roles of cyclin D1. Am J
Pathol. 183:3–9. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Moroishi T, Hansen CG and Guan KL: The
emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 15:73–79.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mizuno T, Murakami H, Fujii M, Ishiguro F,
Tanaka I, Kondo Y, Akatsuka S, Toyokuni S, Yokoi K, Osada H and
Sekido Y: YAP induces malignant mesothelioma cell proliferation by
upregulating transcription of cell cycle-promoting genes. Oncogene.
31:5117–5122. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cao R, Ji H, Feng N, Zhang Y, Yang X,
Andersson P, Sun Y, Tritsaris K, Hansen AJ, Dissing S and Cao Y:
Collaborative interplay between FGF-2 and VEGF-C promotes
lymphangiogenesis and metastasis. Proc Natl Acad Sci USA.
109:15894–15899. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hong W and Guan KL: The YAP and TAZ
transcription co-activators: Key downstream effectors of the
mammalian Hippo pathway. Semin Cell Dev Biol. 23:785–793. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kang W, Tong JH, Chan AW, Lee TL, Lung RW,
Leung PP, So KK, Wu K, Fan D, Yu J, et al: Yes-associated protein 1
exhibits oncogenic property in gastric cancer and its nuclear
accumulation associates with poor prognosis. Clin Cancer Res.
17:2130–2139. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bai F, Guo X, Yang L, Wang J, Shi Y, Zhang
F, Zhai H, Lu Y, Xie H, Wu K and Fan D: Establishment and
characterization of a high metastatic potential in the peritoneum
for human gastric cancer by orthotopic tumor cell implantation. Dig
Dis Sci. 52:1571–1578. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thalheimer A, Otto C, Bueter M, Illert B,
Gattenlohner S, Gasser M, Fein M, Germer CT and Waaga-Gasser AM:
Tumor cell dissemination in a human colon cancer animal model:
Orthotopic implantation or intraportal injection? Eur Surg Res.
42:195–200. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lehnert T, Rudek B, Buhl K and Golling M:
Surgical therapy for loco-regional recurrence and distant
metastasis of gastric cancer. Eur J Surg Oncol. 28:455–461. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jamali M and Chetty R: Predicting
prognosis in gastroentero-pancreatic neuroendocrine tumors: An
overview and the value of Ki-67 immunostaining. Endocr Pathol.
19:282–288. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Duchrow M, Schlüter C, Key G, Kubbutat MH,
Wohlenberg C, Flad HD and Gerdes J: Cell proliferation-associated
nuclear antigen defined by antibody Ki-67: A new kind of cell
cycle-maintaining proteins. Arch Immunol Ther Exp (Warsz).
43:117–121. 1995.PubMed/NCBI
|
|
25
|
Amoedo ND, El-Bacha T, Rodrigues MF and
Rumjanek FD: Cell cycle and energy metabolism in tumor cells:
Strategies for drug therapy. Recent Pat Anticancer Drug Discov.
6:15–25. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Umekita Y, Ohi Y, Sagara Y and Yoshida H:
Overexpression of cyclinD1 predicts for poor prognosis in estrogen
receptor-negative breast cancer patients. Int J Cancer. 98:415–418.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lamar JM, Stern P, Liu H, Schindler JW,
Jiang ZG and Hynes RO: The Hippo pathway target, YAP, promotes
metastasis through its TEAD-interaction domain. Proc Natl Acad Sci
USA. 109:E2441–E2450. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Singh S, Sadanandam A and Singh RK:
Chemokines in tumor angiogenesis and metastasis. Cancer Metastasis
Rev. 26:453–467. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Barzi A and Thara E: Angiogenesis in
esophageal and gastric cancer: a paradigm shift in treatment.
Expert Opin Biol Ther. 14:1319–1332. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tuettenberg J, Friedel C and Vajkoczy P:
Angiogenesis in malignant glioma - a target for antitumor therapy?
Crit Rev Oncol Hematol. 59:181–193. 2006. View Article : Google Scholar : PubMed/NCBI
|
